Integrating cancer genetics with clinical data for better treatment insights
Official title: Research Specialist in Cancer Genomics to Integrate Basic Research and Clinical Data
Funded at Fred Hutchinson Cancer Center · NIH-10899604 · Data updated 2026-11-12
This study is all about figuring out how different factors like genes and the environment affect cancer, and it's designed to help doctors find better ways to treat patients by using advanced computer tools to analyze a lot of data.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 15, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $112,973 |
| NIH project number | 5R50CA274336-02 |
| Project ID | NIH-10899604 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with various types of cancer who are interested in contributing to advancements in cancer genomics.
✕Less likely to help
Patients with non-cancerous conditions or those not interested in genomic research may not receive any benefit from this research.
What this research studies
This research focuses on understanding the complex nature of human cancers by integrating genetic, environmental, and immunological data. It aims to develop new computational tools and methodologies to analyze and interpret large-scale genomic data, which can enhance our understanding of cancer biology and improve precision medicine approaches. By collaborating with various investigators, the project seeks to create a bi-directional integration of laboratory findings and clinical applications, ultimately aiming to improve cancer treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual genetic profiles.
How similar studies have gone: Previous research has shown success in integrating genomic data with clinical outcomes, indicating that this approach has the potential for significant advancements in cancer treatment.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Coleman, Ilsa — Fred Hutchinson Cancer Center
- Study coordinator: Coleman, Ilsa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.